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Abstract
Background: Mental health disorders are a global health concern. In Australia, numerous national reports have
found that the current mental healthcare system does not adequately meet the needs of Australians with mental
illness. Consequently, a greater understanding of how people with a mental health disorder are using the broader
healthcare system is needed. The aim of this paper is to explore conventional and complementary health care use
and expenditure among Australian adults reporting a mental health disorder diagnosis.
Methods: A cross-sectional online survey of 2,019 Australian adults examined socio-demographic characteristics,
complementary and conventional health care use and the health status of participants.
Results: 32 % (n = 641) of the total sample (N = 2019) reported a mental health disorder in the previous 3 years. Of
these, 96 % reported consulting a general practitioner, 90.6 % reported using prescription medicines, 42.4 %
consulted a complementary medicine practitioner, 56.9 % used a complementary medicine product and 23 % used
a complementary medicine practice. The estimated 12-month out-of-pocket health care expenditure among
Australians with a mental health disorder was AUD$ 4,568,267,421 (US$ 3,398,293,672) for conventional health care
practitioners and medicines, and AUD$ 1,183,752,486 (US$ 880,729,891) for complementary medicine practitioners,
products and practices. Older people (50–59 and 60 and over) were less likely to consult a CM practitioner (OR =
0.538, 95% CI [0.373, 0.775]; OR = 0.398, 95% CI [0.273, 0.581] respectively) or a psychologist/counsellor (OR = 0.394,
95% CI [0.243, 0.639]; OR = 0.267, 95% CI [0.160, 0.447] respectively). People either looking for work or not in the
workforce were less likely to visit a CM practitioner (OR = 0.298, 95% CI [0.194, 0.458]; OR = 0.476, 95% CI [0.353,
0.642], respectively).
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: erica.mcintyre@uts.edu.au
1Australian Research Centre in Complementary and Integrative Medicine,
School of Public Health, Faculty of Health, University of Technology Sydney,
2007 Ultimo, NSW, Australia
2Institute for Sustainable Futures, University of Technology Sydney, PO Box
123, 2007 Ultimo, NSW, Australia
Full list of author information is available at the end of the article
McIntyre et al. BMC Health Services Research         (2021) 21:1266 
https://doi.org/10.1186/s12913-021-07162-0
Conclusions: A substantial proportion of Australian adults living with a mental health disorder pay for both
complementary and conventional health care directly out-of-pocket. This finding suggests improved coordination
of healthcare services is needed for individuals living with a mental health disorder. Research examining the
redesign of primary health care provision should also consider whether complementary medicine practitioners and/
or integrative health care service delivery models could play a role in addressing risks associated with
complementary medicine use and the unmet needs of people living with a mental health disorder.
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Background
Mental health disorders (MHD) are a global health con-
cern, with as many as one in three people worldwide,
and one in five Australians, reporting a common MHD
(depression, anxiety or substance use disorder) in the
past 12 months [1, 2]. These disorders are one of the lar-
gest contributors of global disease burden, representing
32 % of years lived with disability from all causes [3]. In
addition, mental health disorders are associated with
lower social and economic participation, diminished
physical health and subsequent chronic illness, lower
standards of living and premature death [4]. Economic
costs, particularly out-of-pocket (OOP) costs, further
contribute to the burden of mental illness by increasing
financial pressures, which in turn, contribute to health
inequities [5, 6].
Despite the considerable burden of MHD, there has
been little evidence of improvement in mental health
outcomes in many countries, including Australia [4].
The Australian Productivity Commission’s (APC)
Inquiry Report [4] recognises that the current mental
health care system does not adequately meet the needs
of Australians with mental illness and has called for sub-
stantial reforms to drive significant change in how men-
tal ill-health is understood and treated. These unmet
health needs may, in part, drive many people with men-
tal health problems to use a variety of health care ser-
vices and interventions [4, 7], including complementary
medicine (CM) services, products and practices that are
not considered part of mainstream health care [7–9].
Previous research has revealed that almost 75 % of
Australian adults experiencing anxiety report using
herbal medicines (a type of CM product) in their life-
time, with relatively fewer (55 %) using prescribed
medications [10]. In people with depressive disorders,
it is estimated that up to 30 % of adults use CM [9].
Given the high rates of CM use among people living
with mental illness, it is not surprising that OOP costs
related to CM use have been shown to be higher than
that reported for conventional pharmaceutical use [6]. A
recent whitepaper by Zurich Australia [11] estimated in-
dividual OOP costs specific to mental health care to be
close to AUD$ 1,350 (US$ 1,004) per annum. Consistent
with mental health care expenditure in general, OOP
costs are continuing to rise, which may result in sub-
standard care or avoidance of care—both contributing to
poor mental health outcomes [5, 11]. As these estimates
are limited to conventional health care use, it is likely
that OOP costs will be substantially greater when CM
use is taken into account.
The multiple factors influencing mental health out-
comes, discussed above, have important policy implica-
tions. In fact, Spinks and Hollingsworth [6] have called
for government action to integrate CM-related issues
into policy, not dissimilar to policies concerning conven-
tional health care use. The reasons for this call for action
are clear. CM users with mental illness are more inclined
to self-treat and less likely to seek professional treatment
[6]. In addition, concurrent CM and conventional medi-
cine use [6, 7], combined with non-disclosure and poor
health literacy, creates myriad health risks (e.g., delayed,
inappropriate or harmful treatment) that are yet to be
meaningfully addressed at the policy level [6, 7, 12].
To address policy gaps pertinent to health care use
and their impacts, it is imperative to understand how
people with a MHD use health services, products and
practices. Alarmingly, there has not been an investiga-
tion of conventional and CM health care use in adults
with a MHD in Australia in over a decade. This study
addresses this knowledge gap by examining conventional
and CM health care use, including OOP costs, among
Australian adults reporting a MHD as well as exploring
the sociodemographic and health-related characteristics
of health service users, and the prevalence and predic-





This study used a sample (N = 2,025) principally repre-
sentative of the Australian population with regards to
age, gender and state/territory of residence as indicated
by Australian Bureau[13] of Statistics data [14]. For a
comparison between this sample and the national popu-
lation data see Steel et al. [13]. Employing a cross-
sectional design, the reported results drew from a sub-
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study analysis of a wider project. Data collection and re-
cruitment was conducted between 26 July and 28 August
2017, by contacting registered participants of Qualtrics
(an online platform used for research participant
recruitment).
Adopting a purposive convenience sampling method,
eligible Australian participants aged 18 years and over,
were contacted by email (N = 41,000) and instructed to
use the weblink provided to obtain further information
about the study. The response rate was 5 %. Respondents
indicating an interest to participate were asked to pro-
vide consent prior to commencing the online survey. All
respondents who completed the survey confirmed their
informed consent. The completion time of the survey
was approximately 15 min. Reflecting the financial in-
centive scheme of registered Qualtrics members, a small
financial reward was offered to participants who com-
pleted the survey.
Measures
The 50-item survey included questions concerning socio-
demographic characteristics, health care use and health
status. Using a convenience sample of seven Australian
adults, the survey items were tested with respect to
response option suitability, question construction and ease
of use. Respondent feedback resulted in minor changes to
the questionnaire.
Health status
Participants were asked if they had been diagnosed with
any health conditions within the last 3 years (yes/no)
from a list of chronic health conditions, including the
following mental health diagnoses: mood disorder (e.g.,
depression), anxiety disorder, sleep disorder, substance
use disorder, schizophrenia or other psychotic disorder,
or other mental health disorder.
Health care use
Participants were asked about their conventional health
care use within the last 12 months including consult-
ation with a primary care physician, allied health worker
(e.g., counsellor), medical specialist, or hospital-based
health care professional (e.g., hospital doctor). The 20-
item Short Form Health Survey (SF-20) was used to
assess health related quality of life across six dimensions
of health: physical functioning, role functioning, social
functioning, mental health (MHI-5), current health
perceptions, and pain [15]. The five items comprising
the MHI-5 measure the frequency of general mental
health symptoms in the previous month on a 6-point
scale (1 = All of the time to 6 = None of the time), with
higher summed scores indicating better mental health.
Participants were also asked to report consultation
frequency, reason for consultation and estimated OOP
costs.
CM use was measured using items from the validated
International Complementary and Alternative Medicine
Questionnaire (I-CAM-Q) [16, 17]. As the I-CAM-Q re-
quires country specific adaptation [18], some changes
were made to reflect Australian cultural contexts. Partic-
ipants were asked about their CM usage within the last
12 months with respect to CM products, mind-body
practices and consultations with CM practitioners. Rea-
sons for these consultations and estimated OOP costs
were also solicited.
Data analysis
IBM SPSS Statistics Premium Edition Version 25
(Armonk, New York, IBM Corp) was used to analyse the
data. Prior to conducting analyses, raw data were
screened for any missing or incomplete responses. Dur-
ing this process, six cases were removed as the data were
deemed unreliable; this included text responses that
were incongruous with the corresponding question, re-
peated patterns throughout the data, and inconsistency
in responses. After removal of the six cases, 2,019 cases
were included in the final data set. Binary variables were
created from categorical variables that related to CM
use, as well as diagnosed illnesses. Mental health diagno-
ses were categorised into four groups for analysis: any
MHD, anxiety disorder, mood disorder, and other MHD
(all excluding anxiety and mood). The total summed
score of the MHI-5 items was transformed a standard
score from to 0 to 100. Descriptive statistics were used
to determine the percentages and frequencies. Chi-
square analysis was used to assess associations between
categorical sociodemographic and health-related vari-
ables. Cramer’s V was used to measure the magnitude of
these associations. Independent t-tests were used to
determine differences between groups for continuous
variables; the Welch t-test was used if the homogeneity
of variance assumption was violated according to
Levene’s test (p > .05). Covariates were included in re-
gression analyses if they were theoretically relevant or
had an association p < .25 [19]. Logistic regression was
used to identify predictors of health care use. Hierarch-
ical multiple regression was used to predict total health
care expenditure from MHD. Statistical significance was
set to p < .05.
Participants’ mean OOP expenditure for health ser-
vices and medicines—inclusive of CM and conventional
health—was used for the economic analysis. As the
economic data were not normally distributed, Mann-
Whitney U tests were used to determine the median dif-
ferences in OOP expenses (continuous variable) between
those with and without a MHD (categorical variable).
Population level OOP expenditure was calculated for the
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estimated number of the Australian population with a
MHD—determined based on the prevalence of MHD
reported in this study multiplied by the number of
Australian adults aged 20 years or above (n = 17, 615,
676) reported in Australian census figures for 2016 [20].
Data for the number of Australian adults 18 to 19 years
was not available. The estimated total expenditure by
Australian population with a MHD was then extrapo-
lated by multiplying the reported mean expenditure by
MHD participants in this study by the estimated number
of Australians with a MHD. Expenses are reported in
Australian dollars.
Ethics
The Human Research Ethics Committee at Endeavour
College of Natural Health provided ethics approval
(20,170,242) in accordance with the National Health and
Medical Research Council Statement on Ethical Conduct
in Human Research. Charles Sturt University (H17048),
The University of Sydney (2017/140) and The University
of Technology Sydney (ETH17-1564) Human Research
Ethics Committees also granted ethics approval.
Results
32 % (n = 641) of the total sample (N = 2019) reported a
MHD in the previous 3 years. Of these, 20 % (n = 402)
reported an anxiety disorder, 19 % (n = 387) a mood
disorder and 18 % (n = 372) at least one other MHD.
The general mental health status for the total sample
(M = 63.63, SD = 22.98) was slightly lower than previously
reported general population means [21]. The mental health
status of those reporting a mood disorder (M = 42.94, SD =
20.54), anxiety disorder (M = 42.97, SD = 20.82) or other
MHD (M = 46.04, SD = 22.47) was consistent with clinical
population norms [22].
Sociodemographic characteristics
Table 1 presents the descriptive statistics for the partici-
pants sociodemographic characteristics and their associ-
ation with each category of MHD (i.e., any MHD,
anxiety disorder, mood disorder, and other MHD). As
detailed in Table 1, there were statistically significant as-
sociations (p < .05) between gender, employment status,
marital status, educational qualification, financial man-
ageability, health care card or private health insurance
and all MHD categories. The magnitude of these associ-
ations were mostly small, with Cramer’s V values
ranging between 0.06 and 0.25. Those who were female
(compared to males), not in the paid workforce (com-
pared to those in the workforce), never married (com-
pared to those who are or have been married), or had a
vocational qualification (compared to those with an
education level at or below year 12) more frequently re-
ported all MHD categories. Participants with a health
care card, compared to those without, reported all cat-
egories of MHD less frequently. In contrast, those who
found financial management difficult some or all of the
time (compared to those finding it not too bad or easy)
and those with private health insurance (compared to
those without) more frequently reported all categories of
MHD.
Age and remoteness of residence was significantly as-
sociated (p < .05) with having either any mental health
disorder, anxiety or a mood disorder, but not with hav-
ing any other mental health disorder (not anxiety or
mood). Participants who were 60 years and over re-
ported any of these diagnoses less frequently than all
other age groups. Compared to those living in outer re-
gional/remote areas, participants living in a major city or
inner regional area more frequently reported having any
MHD.
Health related characteristics
Table 2 summarises the results of Chi-square tests of as-
sociation between MHD, physical health diagnosis and
number of chronic conditions. Each category of MHD
had large significant associations (p < .01) with each
comparable MHD category (Cramer’s V between 0.45
and 0.58). Participants reporting an anxiety disorder,
compared to those without, were more likely to have ei-
ther a mood disorder diagnosis or any other MHD.
Similarly, compared to participants without a mood dis-
order, those reporting a mood disorder diagnosis were
more likely to have any other MHD.
A physical health diagnosis of a cardiovascular, female
reproductive, gastrointestinal, musculoskeletal or re-
spiratory condition were all statistically significantly as-
sociated with each category of MHD (p < .05). However,
the strength of the associations varied according to the
specific category of physical illness diagnosis and MHD.
For example, the association between musculoskeletal
conditions and anxiety disorders was negligible
(Cramer’s V = 0.06), compared to a moderate association
between gastrointestinal disorders and any MHD
(Cramer’s V = 0.23). Participants reporting each of these
physical conditions were more likely to report any
MHD, anxiety or mood disorder, compared to those
without each condition.
Participants with a diabetes diagnosis were more likely
to report having any MHD or other MHD, although the
association was of negligible significance (p = .006,
Cramer’s V = 0.06). Participants reporting other physical
illnesses were significantly (p > .01) more likely to report
a mood disorder, although the association was negligible
(Cramer’s V = 0.06).
Number of chronic conditions had large significant as-
sociations with all categories of MHD (p > .001, Cramer’s
V between 0.55 and 0.67). People with five or more
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illnesses had the highest reported rates of all MHD
categories, including any mental health disorder
(34.2 %), anxiety (39.1 %), mood (45 %) or other MHD
(44.4 %).
Prevalence of conventional and complementary health
care use
All forms of conventional health care use (i.e., medical
doctor, allied health and pharmaceuticals) were signifi-
cantly associated with each MHD category (p < .001);
with the strength of associations ranging between negli-
gible (Cramer’s V = 0.05 for physiotherapist and mood
disorder) to large (Cramer’s V = 0.46 for psychologist/
counsellor and any MHD). Within the medical doctor
category, participants most frequently consulted a gen-
eral practitioner for all categories of MHD (over 96 %),
followed by hospital doctors, who were consulted by be-
tween 41.8 and 47.3 % of participants. Within the allied
health category, most people consulted a pharmacist
across all types of MHD (88–89.9 %), with the lowest
consultation rates reported for community nurses (15.6
to 19.9 %). The highest use of pharmaceutical medicines
related to prescription use across all MHD categories,
including any mental health disorder (90.6 %), anxiety
(92 %), mood (92.8 %) and other (91.1 %). See Table 3 for
summary statistics.
Complementary health care use was categorised as:
CM practitioner consultations, and CM products and
practices (i.e., non-ingestible treatments such as massage
therapies, yoga and Tai Chi). Consulting with any CM
practitioner in the previous 12 months was significantly
associated with each MHD category (p < .001). The sig-
nificance and strength of associations for each type of
CM practitioner varied across MHD categories (see
Table 3). The largest proportion of participants con-
sulted a massage therapist for any MHD (23.9 %), anx-
iety (24.4 %) and other MHD (25.5 %). In contrast,
homeopaths were consulted the least for any MHD
(4.5 %), anxiety (4.2 %) and mood (4.2 %) disorder, and
acupuncturists consulted the least for other MHD
(2.2 %). There were no statistically significant associa-
tions between any specific type of CM practitioner and
people reporting a mood disorder diagnosis.
Use of CM practice or product was significantly asso-
ciated with all MHD categories (p < .05). The signifi-
cance and strength of associations, and the prevalence of
use, for each type of CM practice or product varied by
MHD category (see Table 3). Vitamin or mineral supple-
ments had the highest usage rates across all MHD, in-
cluding any MHD (54.9 %), anxiety (54.7 %), mood
(53.5 %), and other MHD (54.6 %). Relaxation techniques
had the highest prevalence of use of the CM practices,
which were used by 21.4–23.7 % of participants across
all MHD categories.
Out-of-pocket expenditure
On average in the previous 12 months, the total
self-reported OOP expenditure on health care by
each participant with a MHD was AUD$ 1030.06
(US$ 767.12). This extrapolated to estimated OOP
costs of AUD$ 5,752,019,906 (US$ 4,284,028,624)
for health care used by adults with a MHD in
Australia (n = 5,584,169) with AUD$ 4,568,267,421
(US$ 3,398,293,672) for conventional health care
practitioners and medicines, and AUD$ 1,183,752,486
(US$ 880,729,891) for complementary medicine practi-
tioners, products and practices.
The OOP expenditure on each type of health service
and treatment in the previous 12 months is reported in
Table 4. Participants with a MHD, compared to those
without, spent significantly more on both over-the-
counter (OTC) pharmaceutical medicines (U = 377,595,
z = 4.01, p < .000) and prescription medicines (U =
404,783, z = 6.76, p < .000). For those consulting with
conventional health practitioners, those with a MHD
spent significantly more than those without a MHD on
specialist doctors (U = 424,837, z = 5.89, p < .000), hos-
pital doctors (U = 389,032, z = 2.97, p < .000) and coun-
sellors/psychologists (U = 428,171, z = 9.41, p < .000).
For those consulting with a CM practitioner, a signifi-
cant difference in expenses was only found for partici-
pants consulting with a naturopath; those with a MHD
spent significantly more on consultations than those
without a MHD, U = 66,122, z = 2.53, p = .01. For those
who used CM products, participants with a MHD spent
significantly less on yoga, Tai Chi or Qi Gong compared
to those without a diagnosis, U = 14,319, z = -2.86,
p < .000. There was no significant difference in median
expenditure on each type of CM product between par-
ticipants with or without a MHD.
Table 5 presents the results of the hierarchical mul-
tiple regression predicting total health care expenses
from MHD diagnosis. The full model including relevant
sociodemographic variables, chronic physical illness and
MHD (Model 3) was statistically significant (R2 = 0.038,
F(11, 2001) = 7.111, p < .0001, adjusted R2 = 0.033); ac-
counting for less than 4 % of the variance in total health
care expenditure. Employment status, private health in-
surance, chronic physical illness and MHD were all sig-
nificant predictors of total health care expenses in the
final model.
Predictors of type of health practitioner use
The logistic regression models predicting each type of
health practitioner visited were statistically significant
(p < .001; see Table 6). Gender, employment status,
financial management, private health insurance, health
care card, MHD and chronic physical illness diagnosis
were all significant predictors of general practitioner
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consultations (p < .05). Age, qualification level, private
health insurance, MHD and chronic physical illness sig-
nificantly predicted (p < .05) specialist doctor
consultations. For psychologist/counsellor consultations,
six predictor variables were statistically significant
(p < .05): age, marital status, employment status, health
Table 4 Out-of-pocket expenditure on type of health service and treatment used in the previous 12 months















Mean Median Mean Median
Pharmaceuticals
Prescription-only 93,237 812,246,608 145.46 30.00* 82.38 12.00*
Over-the-counter 34,853 303,629,840 54.37 20.00* 32.62 10.00*
Total 128,090 1,115,876,448 199.83 60.00 115.00 30.00
CM products
Vitamins/Mineral Supplements 32,387 282,146,905 50.53 5.00 40.57 0.00
Aromatherapy oils 4,579 39,890,657 7.14 0.00 4.21 0.00
Western/Chinese herbal medicine 4,307 37,521,088 6.72 0.00 5.24 0.00
Homeopathy 4,058 35,351,886 6.33 0.00 2.31 0.00
Flower Essences 2,369 20,670,152 3.70 0.00 1.99 0.00
Total 47,580 415,580,687 74.34 10.00 54.48 0.00
CHC practitioner
General practitioner 203,829 1,775,687,082 317.99 0.00 43.10 0.00
Specialist doctor 89,775 782,086,866 140.05 0.00* 111.52 0.00*
Hospital doctor 47,855 416,896,133 74.66 0.00* 17.88 0.00*
Counsellor/Psychologist 38,287 333,543,042 59.73 0.00* 11.08 0.00*
Community nurse 2,825 24,610,418 4.41 0.00 3.16 0.00
Physiotherapist 13,725 119,567,431 21.41 0.00 19.04 0.00
Total 396,2956 3,452,390,973 618.25 60.00 205.80 25.00
CM practitioner
Massage therapist 17,853 155,772,147 27.90 0.00 16.77 0.00
Chiropractor 15,418 134,316,259 24.05 0.00 12.57 0.00
Yoga teacher 3,463 30,168,453 5.40 0.00 4.74 0.00
Acupuncturist 7,431 64,837,441 11.61 0.00 5.13 0.00
Naturopath 10,169 88,588,795 15.86 0.00* 4.02 0.00*
Osteopath 4,334 37,756,302 6.76 0.00 3.99 0.00
TCM practitioner 3,537 30,813,115 5.52 0.00 4.07 0.00
Aromatherapist 8,992 78,335,180 14.03 0.00 2.10 0.00
Homeopath 3,268 28,469,681 5.10 0.00 3.36 0.00
Western Herbalist 3,731 32,503,176 5.82 0.00 2.77 0.00
Total 70,532 681,560,548 110.38 0.00 59.41 0.00
CM practices
Yoga/tai chi 4,076 35,508,696 6.36 0.00* 6.58 0.00*
Relaxation/
meditation
5,866 51,102,554 9.15 0.00 3.36 0.00
Total 9,942 86,611,250 15.51 0.00 9.95 0.00
Note. AUD Australian dollars, MHD mental health disorder, CHC conventional health care, CM complementary medicine, TCM traditional Chinese medicine. aThe
estimated number of the Australian population with a MHD was calculated based on Australian census figures in year 2016 for Australian adults aged 20 years or
above (n = 17,615,676) and the reported prevalence of mental health disorders in this study (31.7 %). *Indicates a significant difference between median expenses
of MHD and no-MHD groups (p < .05)
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care card, MHD and chronic physical illness. CM practi-
tioner consultations were significantly (p < .05) predicted
by gender, age, employment status, private health insur-
ance, MHD, and chronic physical illness.
Males were less likely to see a general practitioner
(OR = 0.666, 95% CI [0.490, 0.905]) or any CM prac-
titioner than females (OR = 0.709, 95% CI [0.573,
0.878]). Being 50–59 years old was associated with
an increased likelihood of consulting with a specialist
doctor. In contrast, older people aged 50–59 and 60
and over were less likely to consult a CM practi-
tioner (OR = 0.538, 95% CI [0.373, 0.775]; OR = 0.398,
95% CI [0.273, 0.581] respectively) or a psychologist/
counsellor (OR = 0.394, 95% CI [0.243, 0.639]; OR =
0.267, 95% CI [0.160, 0.447] respectively). Partici-
pants either in casual/temp work or looking for work
were almost twice as likely to visit a psychologist or
counsellor (OR = 1.812, 95% CI [1.088, 3.017]; OR =
1.886, 95% CI [1.156, 3.078], respectively); similarly
people either looking for work or not in the work-
force were less likely to visit a CM practitioner
(OR = 0.298, 95% CI [0.194, 0.458]; OR = 0.476, 95%
CI [0.353, 0.642], respectively). People with a MHD
or chronic physical illness were more likely to con-
sult with any health practitioner compared to those
without a MHD or chronic physical illness
respectively.
Predictors of type of health treatment use
Table 7 summarises the results of the four logistic re-
gression models predicting each type of health treatment
used, which were statistically significant (p < .001). Pre-
scription pharmaceutical use was significantly (p < .05)
predicted by age, financial management, private health
insurance, MHD and chronic physical illness. Gender,
age, area of residence, private health insurance, MHD
and chronic physical illness were significant predictors
of OTC pharmaceutical use (p < .05). Gender, qualifica-
tion level, private health insurance MHD and chronic
physical illness significantly predicted CM product use
(p < .05), whilst age, qualification level, health care card
and MHD significantly predicted CM mind-body prac-
tice use (p < .05).
Males were less likely to use OTC pharmaceuticals
(OR = 0.739, 95% CI [0.600, 0.910]), CM products (OR =
0.563, 95% CI [0.461, 0.687]) or prescription pharmaceu-
ticals (OR = 0.791, 95% CI [0.610, 1.010]) than males.
Those 60 and over were twice as likely to use prescrip-
tion pharmaceuticals (OR = 2.04, 95% CI [1.307, 3.182])
than those in the youngest age group (18–29 years),
while those in the 40–49 age group were more likely to
use OTC pharmaceuticals (OR = 1.598, 95% CI [1.135,
2.250]). In contrast, all older age groups were less likely
to use CM mind-body practices compared to the youn-
gest age group. Those who’s financial management was
Table 5 Hierarchical multiple regression predicting total health care expenses
Total health care expenses
Model 1 Model 2 Model 3
Variable B ß B ß B ß
Constant 1058.57** 947.58** 557.54*
Gender -44.28 -0.02 -26.49 -0.01 -4.91 0.00
Age -3.04 0.00 -28.13 -0.04 -16.31 -0.02
ARIA+ 14.96 0.01 11.24 0.01 12.88 0.01
Marital status 18.79 0.02 15.70 0.02 9.65 0.01
Highest qualification -24.08 -0.02 -25.55 -0.03 -26.49 -0.03
Financial manageability -1.40 0.00 -0.64 0.00 25.00 0.02
Employment status -22.80 -0.04 -32.53 -0.05 -41.52* -0.07
Private health insurance -229.92** -0.11 -215.56** -0.10 -221.35** -0.10
Health care card -50.84 -0.02 -36.40 -0.02 -25.24 -0.01
Chronic physical illness 288.46** 0.13 248.56** 0.12
Mental health disorder 244.56** 0.11
R2 0.012 0.028 0.038
F 2.72* 5.74** 7.11**
ΔR2 0.012* 0.016** 0.010**
Note. *p < .05, **p < .001. B = Unstandardised regression coefficient, ß = Standardised regression coefficient, ΔR2 = squared part correlations. The Australian health
care card is a concessions card providing discounted medicines and services to eligible low income patients and is funded by the Australian Federal Government.
ARIA is the Accessibility/Remoteness Index of Australia supported and utilised by the Commonwealth Dept of Health and the Australian Bureau of Statistics. ACT is
the Australian Capital Territory
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either “not too bad” or “easy”, or had private health in-
surance were less likely to use prescription pharmaceuti-
cals. Those with PHI were also less likely to use OTC
pharmaceuticals or CM products, while those with a
health care cared were less likely to use mind-body prac-
tices. As a participant’s qualification level rose, the
greater the likelihood of the participant reporting CM
product or mind-body practice use. Those with a MHD
were more likely to use any type of health treatment
compared to those without a MHD, with prescription
pharmaceuticals having the greatest increased odds of
being used (OR = 4.045, 95% CI [2.944, 5.558]). People
reporting a chronic physical illness were also more likely
to use prescription or OTC pharmaceuticals or CM
products, but not mind-body practices.
Discussion
This nationally representative study provides insights
into the prevalence, sociodemographic, and health-
related characteristics of Australian adults reporting a
MHD. The findings also shed light on conventional and
CM health care use, including OOP costs, in this popu-
lation. Of significance is the identification of predictors
of health care use and type of health practitioner or
treatment use. Having an MHD diagnosis was an im-
portant predictor of all types of health care use. This is
consistent with previous research indicating that people
with a mental health condition are high users of conven-
tional health care [4, 23] or CM health care [7].
In the current study, people with a MHD were more
likely to use all types of conventional health care (i.e.,
doctors, allied health, prescribed pharmaceutical medi-
cines, and OTC pharmaceutical medicines). When con-
trolling for all other variables, having a MHD was the
most important predictor of consultations with psychol-
ogists/counsellors (i.e., those with an MHD were more
likely to consult with them) being almost ten times more
likely to consult with them than those without a MHD.
We also found that having a MHD was an important
predictor of all types of ingestible medicine use. Of spe-
cific interest was the finding that people with a MHD
were four times more likely than those without a MHD
to be using a prescription pharmaceutical medicine.
These results reflect similar findings from the APC
Report [4], which found that people with a MHD were
high users of primary health care practitioners, particu-
larly general practitioners and psychologists, and high
users of prescribed medication. The immediate concern
with such prevalent use of both complementary and
pharmaceutical medicines is the potential for medicine in-
teractions or inappropriate medicine use. Importantly, the
high prevalence of comorbid chronic conditions reported
by people with a MHD is likely to be driving high medi-
cines use and polypharmacy. This is consistent with our
finding that those with a chronic physical condition were
more likely than those without to use all types of medicines.
Collectively, multiple conventional and complementary
health care practitioners involved in the care of a person
with a MHD and self-prescribing of CMs, coupled with
poor interprofessional communication is likely to increase
the potential for medicines interactions [24]. This further
supports the need for a more coordinated approach to
health service provision (including the prescribing of medi-
cines) for people living with a MHD.
The findings from our study suggest mental health
consumers are using CM health services for different
needs. For example, we found that although having a
mood disorder was associated with consulting with at
least one type of CM practitioner, it was not associated
with any specific type of CM practitioner; in contrast,
those with an anxiety disorder diagnosis were more
likely to consult with particular types of CM practi-
tioners such as massage therapists. Results from previous
studies investigating CM use for mental health condi-
tions are mixed [8–10]. A lack of research on this topic,
inconsistent research designs and heterogeneity of vari-
ables make it difficult to draw appropriate comparisons
between the results obtained from the current study and
that reported in other studies. Further research is needed
to provide a clearer picture of how a specific MHD may
or may not influence a patient’s choice of CM health
services.
Considerable investigation has been undertaken to
understand how the needs of people with a mental
illness can be met. Consultation with mental health
services, practitioners and consumers, together with nu-
merous government reports draw the same conclusion—
the current needs of mental health consumers are not
being met [4, 25, 26]. Similarly, these key stakeholders
advocate for a redesign of primary health care service
delivery, especially reduction of service fragmentation
and a lack of seamlessness with other health care pro-
viders, whether at the practitioner or health service level.
These discussions, including further research examining
the merits of varying models of health care to address
these unmet needs, are vital.
The results from this study show that Australians with
a MHD were high users of CM and that this may be an
attempt to fill, or be filling, an unmet need. Research
examining the merits of integrative health care models
within primary care (those that are clinically governed
by a general practitioner who can act as a gatekeeper in
regards to CM use and work collaboratively with CM
practitioners or directly provide CM treatments) [27–
29], suggests that this model has a role to play in helping
to address the current issues concerning mental health
care [30–32]. To date, the role of CM practitioners as a
mental health resource and their role in connection with
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existing conventional health care service provision has
not been widely discussed. Not only is further research
required to comprehensively evaluate the appropriate-
ness of this health care model, but the known public
health risks related to CM use and how best to respond
to these risks also necessitates national deliberation. An
example of this can be drawn from a key discussion con-
tained in the APC Report regarding OOP costs.
The APC Report states “consumers can incur sizable
out of pocket costs when accessing treatment” [4, pg.
150], which reflects the findings of our study as well as
other reports [5, 11, 33]. The APC acknowledges that
data concerning OOP costs for consumers is limited.
Furthermore, these reports do not include CM use.
Accounting for the impact of CM use on OOP costs can
be a complicated matter, as rebate funding via either the
public (Medicare) or private systems (private health in-
surance) or a consumers socioeconomic status (SES; i.e.,
discretionary spending capacity) can have a differential
impact on the decision-making process regarding choice
of health care services or treatments, and in turn, overall
OOP costs [6, 34]. The cost of mental health care is
known to be a factor in help-seeking, obtaining treat-
ment and support in both the short and longer term,
and is correlated with subsequent mental or physical
health status [35].
The results of our study found that, in general, those
with a MHD did not spend more on CM. Potential rea-
sons for this may be the absence or presence of Medi-
care or private health insurance rebates, or the SES of
the consumer, but other factors also could be at play.
Such factors may include the influence of health literacy
level, personal ideology or close peers on health care
choices. Our findings highlight important omissions
from the current national mental health care discourse
related to economic factors. These include a high
amount of mental health consumer spending on CM
services, practices or products that may or may not be
evidence-based, as well as a perceived benefit of CM by
the consumer. These are important considerations as fi-
nancial decisions about health care may result in delays
in help-seeking, treatment and diagnosis. More needs to
be understood about the economic factors driving both
conventional and CM health care choices and how OOP
costs ultimately impact mental health outcomes.
Our study has several limitations that should be con-
sidered when interpreting our results. The study may be
vulnerable to random error due to sampling bias; how-
ever, as the participants were nationally consistent based
on gender and age [13], this is likely to have minimal
impact on the outcome of our analyses. As this was an
online study it may not adequately represent Aboriginal
and Torres Strait Islander peoples and other population
groups who have less access to the Internet. Recall bias
is a possibility given the self-reported nature of the
study, and the 12-month timeframe of many questions.
Participant’s mental health diagnosis was also susceptible
to self-report without a confirmatory diagnosis by a
qualified health professional; consequently, the data is
vulnerable to detection bias. In addition, the self-
reported mental health diagnosis relies upon the individ-
ual being aware of a mental health condition and seeking
care, and the health care capacity being in place to diag-
nose mental health disorders. Consequentially, the study
is likely to underestimate the real mental health problem
and related expenditures in the population studied. Fi-
nally, identifying the income of the study participants
and collecting data on the resident to provider ratio
(possibly important in accessing care) would both have
provided useful additional insights to the analysis but
unfortunately such information was not collected in the
study.
The increasing prevalence of MHD and associated CM
use in Australia warrants closer examination. The public
health implications of CM use among mental health
consumers requires national discussion with a diverse
range of key stakeholders to ensure there is an appropri-
ate response at the health care service level, right
through to policy. Current research examining the re-
design of primary health care provision should also con-
sider whether CM practitioners and/or integrative health
care service delivery models could play a role in address-
ing known risks associated with CM use and the unmet
needs of people living with an MHD.
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